Latest News

Mpox continues to menace Burundi

Children in the region are worst-affected, and survivors report struggling with social stigma, but recent reports suggest spread may be plateauing.

Finding new ways to engage communities in vaccinations in Kenya

Q&A with Lillyan Mutua about the challenges she encounters in her efforts to increase the uptake of the HPV vaccine and the importance of storytelling to spread awareness.

Bangladesh embraces HPV vaccination

Millions of adolescent girls from seven divisions of Bangladesh are joining their peers in the Dhaka Division for the second phase of the lifesaving human papillomavirus (HPV) vaccination campaigns.

In the DRC, the malaria vaccine ushers in a new chapter in the fight against the disease

Congolese families express hope that an additional layer of protection will make all the difference against the killer infection.

WhatsApp, Doc? Health workers in Africa deploy ordinary apps to make an extraordinary difference

Popular messaging apps are so widely used in African countries that frontline workers report effectively leveraging them to extend the reach of preventive care.

Mystery disease kills dozens in Congo – what we know so far

Several dozen people have died from an unknown disease in the DRC, and unknown numbers have become ill. This is why we need better disease surveillance.

CSO partnerships in immunisation: driving positive change together

For mothers in Uganda’s tea fields, taking their children to get vaccinated can mean missing a day of earnings for food. InPact’s Executive Director writes for VaccinesWork on how her organisation is helping tackle this impossible dilemma.

Zimbabwe rolls out mass drug administration campaign to tackle elephantiasis

Lymphatic filariasis is a preventable parasitic infection. Once its effects become chronic, however, the disease can be permanently disabling and hard to manage.

Indonesia pledges US$ 30 million to support global immunisation efforts through Gavi

Indonesia becomes a new Gavi donor with pledge of US$ 30 million for Gavi’s 2026–2030 strategic period, “Gavi 6.0”.

Subscribe to our newsletter